Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200mg twice daily to nevirapine extended release 400mg once daily (TRANxITION).

Authors
Publication date
1 April 2012
Publisher
Health Sciences Research Commons

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    George Washington University: Health Sciences Research Commons (HSRC)

    redirect
    oaioai:hsrc.himmelfarb.gwu.edu:sm...
    Last time updated on 17/10/2019